Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene.
about
Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Safety and immunogenicity of a ...... ed in alum or polyphosphazene.
@en
Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV
@nl
type
label
Safety and immunogenicity of a ...... ed in alum or polyphosphazene.
@en
Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV
@nl
prefLabel
Safety and immunogenicity of a ...... ed in alum or polyphosphazene.
@en
Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV
@nl
P2093
P1433
P1476
Safety and immunogenicity of a ...... ted in alum or polyphosphazene
@en
P2093
LL Jagodzinski
NL Michael
RJ O'Connell
VR Polonis
P2888
P304
P356
10.1186/1742-4690-9-S2-O50
P433
P577
2012-09-13T00:00:00Z
P6179
1019440392